RecruitingPhase 3NCT05980949Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb companyAnaheim, CA · Chino, CA · +145 more sites
RecruitingPhase 3NCT07177352Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesSponsor: Hoffmann-La RocheImperial, CA · Irvine, CA · Long Beach, CA · +65 more sites
RecruitingPhase 2NCT06847321Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's DiseaseSponsor: Lighthouse Pharmaceuticals, Inc.Murrieta, CA · Oakland, CA · Orange, CA · +36 more sites
RecruitingPhase 2NCT06808984Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseaseSponsor: CelgeneAnaheim, CA · Chino, CA · La Jolla, CA · +57 more sites